Ellomay Capital has been growing earnings at an average annual rate of 6.3%, while the Renewable Energy industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 2.6% per year.
Key information
6.35%
Earnings growth rate
7.59%
EPS growth rate
Renewable Energy Industry Growth
36.01%
Revenue growth rate
2.60%
Return on equity
-15.44%
Net Margin
-46.16%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Ellomay Capital makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
DB:NUR Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
43
-20
7
0
31 Dec 25
43
-2
6
0
30 Sep 25
40
-12
6
0
30 Jun 25
41
-5
6
0
31 Mar 25
41
5
6
0
31 Dec 24
40
-7
6
0
30 Sep 24
40
-2
6
0
30 Jun 24
43
-3
6
0
31 Mar 24
45
-3
5
0
31 Dec 23
49
4
5
0
30 Sep 23
50
14
5
0
30 Jun 23
48
6
5
0
31 Mar 23
54
6
6
0
31 Dec 22
52
-1
6
0
30 Sep 22
56
-12
7
0
30 Jun 22
55
-11
6
0
31 Mar 22
49
-16
6
0
31 Dec 21
45
-16
6
0
30 Sep 21
36
-7
5
0
30 Jun 21
26
-6
5
0
31 Mar 21
15
-5
5
0
31 Dec 20
10
-5
5
0
30 Sep 20
10
9
4
0
30 Jun 20
13
11
4
0
31 Mar 20
16
11
4
0
31 Dec 19
19
12
4
0
30 Sep 19
20
-1
4
0
30 Jun 19
20
-1
4
0
31 Mar 19
20
1
3
0
31 Dec 18
18
1
4
0
30 Sep 18
17
-2
3
0
30 Jun 18
15
-2
3
0
31 Mar 18
14
-5
3
0
31 Dec 17
14
-6
2
0
30 Sep 17
12
-2
4
0
30 Jun 17
13
-4
2
0
31 Mar 17
12
0
2
0
31 Dec 16
12
0
2
0
30 Sep 16
11
-2
4
0
30 Jun 16
12
3
3
0
31 Mar 16
12
2
3
0
31 Dec 15
12
8
2
0
30 Sep 15
13
8
3
0
30 Jun 15
14
9
3
0
Quality Earnings: NUR is currently unprofitable.
Growing Profit Margin: NUR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NUR is unprofitable, but has reduced losses over the past 5 years at a rate of 6.3% per year.
Accelerating Growth: Unable to compare NUR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NUR is unprofitable, making it difficult to compare its past year earnings growth to the Renewable Energy industry (-3%).
Return on Equity
High ROE: NUR has a negative Return on Equity (-15.44%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/25 23:26
End of Day Share Price
2026/06/25 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ellomay Capital Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.